Komori
Other Disclosures2395SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.Information and Communications, Services and Others

Support for those affected by the 2026 Kumamoto Earthquake

Shin Nippon Biomedical Laboratories sent a ¥1 million donation through the Japanese Red Cross Society to support people affected by the 2026 Kumamoto Earthquake.

Worth reading
41Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
100
¥10,000
Wording
Definitive
How definitive the wording is.

Announced details

Applicable field (uses covered by this announcement)

Support for people affected by the 2026 Kumamoto Earthquake

Launch date4 August 2026 (completed)
Relationship between the counterparty and the company
SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.2395
Relationship with the Company

Recipient and intermediary for the donation

CounterpartyJapanese Red Cross Society

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
CounterpartyJapanese Red Cross Society
Relationship with the CompanyRecipient and intermediary for the donation
Launch date4 August 2026 (completed)
Applicable areaSupport for people affected by the 2026 Kumamoto Earthquake
Items this document does not state (14)
Names of Products / Services CoveredCounterparty overviewContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To support people affected by the disaster.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Support for those affected by the 2026 Kumamoto Earthquake | SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. (2395) timely disclosure | Komori